We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





First Ever COVID-19 Portable Sweat Test Device Delivers Results in 30 Seconds

By LabMedica International staff writers
Posted on 13 Sep 2021
A first-ever COVID-19 portable sweat test device can yield instant results and could support proactive screening in the community.

Researchers at Chulalongkorn University (Bangkok, Thailand) have successfully developed, for the first time, a quick and easy-to-use portable sweat test device for COVID-19 to detect specific scents in sweat caused by bacteria. More...
Sample collection only takes 15 minutes per person, and the results can be obtained in 30 seconds. The sweat test is now being used in community screening. The test is based on the success of the “COVID-19 Sniffer Dogs” project that uses sweat sniffer dogs to detect asymptomatic COVID-19 cases in the community.

People’s sweat may have more than 100 unique scents — be it from the powder, roll-on deodorant, or the bacteria that feed on sweat or skin secretions, then excrete the substances that are mixed with sweat. The portable sweat test device was developed from a commercially available portable chemistry analyzer which is generally used to measure chemicals that are toxic to the environment. To adapt it to detect COVID-19, the researchers installed a specific filter to detect the virus. The advantage of this method is that it can be adapted to detect mutated variants of the virus or other microorganisms. Field tests of the device on 2,000 people alongside the PCR (Polymerase Chain Reaction) testing found the results to be on a par – with 95% sensitivity and 98% specificity.

“For those infected with COVID-19, the bacteria react abnormally to the virus and produce some distinct odors unique to COVID-19 infection,” explained Asst. Prof. Dr. Chadin Kulsing, Department of Chemistry, Faculty of Science, Chulalongkorn University. “The test kit consists of a glass vial and a cotton swab which screeners will receive one each. The screeners would place the cotton swab under the armpit of the person receiving the test and leave it for about 15 minutes. After that, the cotton swab is put in the glass vile, which is then sterilized with UV rays. The technician then draws an appropriate amount of the sample using a suction hose, and pressurizes it into the analyzer to check the results.”

Related Links:
Chulalongkorn University


Gold Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.